TOP2A and breast cancer: Numerous studies indicated that TOP2A is highly expressed in a variety of malignant tumors, such as colorectal cancer [38], meningioma [39], breast cancer [40], adrenocortical carcinoma [41], NSCLC [42] and SCLC [43, 44].